Journal archive for Google Scholar Robot!
Iranian Journal of Blood and Cancer
Home
|
All volumes
|
All issues
|
All articles
Volume 3, Number 3 (2011-5)
WHO Recommendations for the production, control and regulation of human plasma for fractionation
|
[PDF-FA]
|
[XML]
|
Securing Safe Plasma for Fractionation the Duty of any Country
|
[PDF-FA]
|
[XML]
|
Pathogen Reduction of Plasma
|
[PDF-FA]
|
[XML]
|
Plasma Fractionation Industry Project in Turkey: Country’s Experiences
|
[PDF-FA]
|
[XML]
|
Patients Perspective in Plasma Products (Focus on Hemophilia)
|
[PDF-FA]
|
[XML]
|
Clinical application of plasma derived medicines: current situation and future trend
|
[PDF-FA]
|
[XML]
|
Access and Rational use of Plasma Protein Therapies (PPTs)
|
[PDF-FA]
|
[XML]
|
Hyperimmunes Plasma Procurement and Products
|
[PDF-FA]
|
[XML]
|
Quality Assurance and Good Manufacturing Practice in Respect of Plasma Fractionation
|
[PDF-FA]
|
[XML]
|
Plasma derived versus biotechnological manufactured medicine
|
[PDF-FA]
|
[XML]
|
Making plasma derived medicines available
|
[PDF-FA]
|
[XML]
|
Worldwide Supply and Demand of Plasma And Plasma-Derived Medicines
|
[PDF-FA]
|
[XML]
|
Plasma Fractionation in Malaysia
|
[PDF-FA]
|
[XML]
|
Self Sufficiency In Plasma And Plasma Derived Medicines
|
[PDF-FA]
|
[XML]
|
Message of President of ISBT to 2nd International Conference on Transfusion Medicine/Plasma Industry in Tehran, Iran, May 10-11, 2011
|
[PDF-FA]
|
[XML]
|
Home
|
All volumes
|
All issues
|
All articles